Immunostimulatory CpG treatment for genital HSV-2 infections.
Herbst
Melissa M
MM
Sealy Center for Vaccine Development and Department of Pediatrics, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555-0436, USA.
Pyles
Richard B
RB
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D018899:CpG Islands / Q000187:drug effects*; D024882:Drug Resistance, Viral; D006168:Guinea Pigs; D006558:Herpes Genitalis / Q000628:therapy* / Q000635:transmission; D018258:Herpesvirus 2, Human / Q000187:drug effects* / Q000235:genetics*; D022283:Herpesvirus Vaccines / Q000627:therapeutic use; D006801:Humans; D051379:Mice
D000276:Adjuvants, Immunologic; D022283:Herpesvirus Vaccines